Biogen (BIIB) Asset Writedowns and Impairment (2009 - 2026)
Biogen's Asset Writedowns and Impairment was $4.8 million in Q1 2026, down 34.2% from $7.3 million a year earlier and down 87.7% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends
For FY2025, Asset Writedowns and Impairment at Biogen came in at $52.9 million, down 48.1% from FY2024.
- Asset Writedowns and Impairment has now declined for four consecutive years, with a five-year compound annual growth rate of -24.1% (FY2020 to FY2025).
- In earlier years, Asset Writedowns and Impairment was $101.9 million in FY2024 (-18.1%), $124.4 million in FY2023 (-63.0%), $336.2 million in FY2022 (-46.6%) and $629.3 million in FY2021 (+200.1%).
- Quarterly Asset Writedowns and Impairment has moved between $3.5 million (Q2 2025) and $541.6 million (Q2 2021) over five years.
- Compared with a year earlier, Asset Writedowns and Impairment was higher in 1 of the last four quarters, with an average decline of 34.2%.
- The best year-over-year quarter for Asset Writedowns and Impairment over five years was Q1 2022 (growth of 535.4%); the worst was Q2 2022 (a decline of 95.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Biogen | 37.04 Bn | 23.70 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 39.00 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 33.20 Mn |
| Sep 30, 2024 | 20.20 Mn |
| Mar 31, 2024 | 27.50 Mn |
| Dec 31, 2023 | 62.30 Mn |
| Jun 30, 2023 | 19.40 Mn |
| Mar 31, 2023 | 17.40 Mn |
| Dec 31, 2022 | 14.60 Mn |
| Sep 30, 2022 | 16.00 Mn |
| Jun 30, 2022 | 24.10 Mn |
| Mar 31, 2022 | 281.50 Mn |
| Sep 30, 2021 | 43.40 Mn |
| Jun 30, 2021 | 541.60 Mn |
| Mar 31, 2021 | 44.30 Mn |
| Dec 31, 2020 | 190.40 Mn |
| Sep 30, 2020 | 19.30 Mn |
| Mar 31, 2012 | 12.40 Mn |
API Access
Biogen Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();